Hematology/Oncology

Top Story

FDA extends authority over e-cigarettes, cigars, hookah tobacco

FDA extends authority over e-cigarettes, cigars, hookah tobacco
May 5, 2016

Read the Perspective from Benard P. Dreyer, MD

The FDA today extended its regulatory authority over all tobacco products, including e-cigarettes, cigars and hookah tobacco, prohibiting retailers from selling these products to persons aged younger than 18 years, according to a press release.

The regulations, which help implement the Family Smoking Prevention and Tobacco Control Act of 2009, will go into effect in 90 days.

In the Journals

Low vitamin D increases risk for adverse pathology of localized prostate cancer

May 5, 2016
Vitamin D deficiency or insufficiency appeared associated with elevated risk for adverse pathology in men with localized prostate cancer who underwent radical…
Meeting News CoverageVideo

VIDEO: Liquid biopsy technology a ‘major advance’ but still requires validation

May 5, 2016
NEW ORLEANS — David Polsky, MD, PhD, professor of dermatology and pathology at NYU School of Medicine and NYU Langone Medical Center, offers insights into…
In the Journals

Recombinant coagulation Factor IX albumin fusion protein shows promise for hemophilia B

May 5, 2016
A long-acting recombinant fusion protein that links coagulation Factor IX with albumin appeared safe and effective for the prevention and treatment of bleeding episodes…
Video

VIDEO: HSCT in patients with ALL, AML, MDS requires early referral, planning

May 5, 2016
The approach to hematopoietic stem cell transplantation is “very similar” in patients with acute lymphoblastic leukemia, acute myeloid leukemia and…
More News Headlines »
CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Video
Meeting News Coverage

VIDEO: Entrectinib safely, effectively treats gene-mutated cancers

May 2, 2016
More »
Featured
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan morganatic-roan